HCPCS Code U0003

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r
Code effective May 12, 2023

HCPCS Section
Codes for Coronavirus Lab Tests

U0003 is a valid 2026 HCPCS code meaning Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r or (Cov-19 amp prb hgh thruput) for short. HCPCS U0003 has been effective since 05/12/2023 and applies to Diagnostic laboratory.

HCPCS Code Details - U0003

HCPCS Level II Code
Section U - Codes for Coronavirus Lab Tests
HCPCS Code U0003
Description

Long description:
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r

Short description:
Cov-19 amp prb hgh thruput

HCPCS Pricing indicator 22 - Durable Medical Equipment, Prosthetics, Orthotics - Price established by carriers (e.g., gap-fills, carrier established panels)
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code T1H - Lab tests - other (non-Medicare fee schedule)
HCPCS Action code N - No maintenance for this code
Type of service 5 - Diagnostic laboratory
Effective date Effective May 12, 2023
Date added Added Apr 14, 2020
Termination date May 11, 2023

See also

  • HCPCS U0002 · 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc

  • HCPCS G0476 · Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test

  • HCPCS G0567 · Infectious agent detection by nucleic acid (dna or rna); hepatitis c, screening, amplified probe technique

  • HCPCS U0005 · Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2

  • HCPCS U0004 · 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.